NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

Area of Science:

• Oncology
• Gynecologic Oncology
• Clinical Guidelines

Background:

• Cervical cancer management requires comprehensive guidelines covering diagnosis, staging, pathology, and treatment.
• The treatment of advanced cervical cancer, particularly recurrent or metastatic disease, is a dynamic field.
• Accurate histopathologic classification is crucial for determining clinical outcomes.

Purpose of the Study:

• To summarize recent updates to the NCCN Guidelines for Cervical Cancer.
• To highlight changes in systemic therapy recommendations for recurrent or metastatic cervical cancer.
• To provide clinicians with current evidence-based management strategies.

Main Methods:

• Review of the latest NCCN Guidelines for Cervical Cancer.
• Analysis of updates pertaining to systemic therapy for advanced disease.
• Synthesis of recommendations for histopathologic classification and molecular profiling.

Main Results:

• The NCCN Guidelines provide a framework for cervical cancer diagnosis, staging, and treatment.
• Detailed histopathologic classification includes diagnostic features, molecular profiles, and outcomes.
• Recent updates focus on systemic therapy advancements for recurrent or metastatic cervical cancer.

Conclusions:

• The NCCN Guidelines offer essential, up-to-date recommendations for cervical cancer care.
• Continuous evolution in systemic therapy necessitates regular guideline updates.
• These insights aid clinicians in managing advanced cervical cancer effectively.